Chiron Real Estate Inc.
XRN NYSE Real Estate Investment Trusts Financials FY2016–FY2025
Last close · Oct 23, 2026
$30.00
0.5%What Chiron Real Estate Inc. does
No business description yet.
- Legal name
- Chiron Real Estate Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 2, 2026
- Accession · CIK
- 0001104659-26-021956
0001533615
Revenue and margins
Chiron Real Estate Inc. had $148M of revenue in fiscal 2025, up 6.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was — in fiscal 2025, — of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Chiron Real Estate Inc. returned $11.8M to shareholders in fiscal 2025. The diluted share count rose 1.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Chiron Real Estate Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $7.2M | $4.0M | $1.3M | $6.8M | $9.1M |
| Debt incl. finance leases | — | — | — | $14.4M | $1.2M |
| Debt / equity | — | — | — | 0.0x | 0.0x |
| Total assets | $1.3B | $1.4B | $1.3B | $1.3B | $1.2B |
| Total liabilities | $626M | $744M | $662M | $701M | $712M |
| Shareholders' equity | $623M | $633M | $584M | $534M | $510M |
| Net debt (− = net cash) | — | — | — | $7.6M | −$7.9M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✕ | ✕ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✕ |
| Cash from operations is positive | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | ✓ | ✓ | ✕ | ✕ | ✓ | ✕ | ✓ | ✕ | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | — | — | — | — | — | — | — | — | ✓ |
| Current ratio rose | — | — | — | — | — | — | — | — | — | — |
| Share count didn't rise | — | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✓ | ✕ | ✕ |
| Gross margin rose | — | — | — | — | — | — | — | — | — | — |
| Revenue rose relative to assets | — | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ |
| F-score | — / 3 | — / 6 | — / 6 | — / 6 | — / 6 | — / 6 | — / 6 | — / 6 | — / 6 | 4 / 7 |
| Accruals ratio | −1.8% | −3.6% | −1.9% | −3.5% | −3.7% | −4.3% | −4.3% | −3.5% | −5.0% | −6.4% |
| Altman Z'' | — | — | — | — | — | — | — | — | — | — |
10 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $8.2M | $30.3M | $53.2M | $70.7M | $93.7M | $116M | $137M | $141M | $139M | $148M |
| Interest expense | $4.1M | $7.4M | $15.0M | $17.5M | $18.7M | $19.7M | $25.2M | $30.9M | $28.7M | $31.8M |
| Net income | −$6.4M | −$0.1M | $14.6M | $9.6M | −$2.5M | $18.3M | $20.0M | $21.7M | $6.7M | −$6.9M |
| Net income to common | −$6.4M | −$1.8M | $7.7M | $3.4M | −$7.7M | $11.8M | $13.3M | $14.8M | $0.8M | −$12.1M |
| Diluted EPS | −$0.68 | −$0.09 | $0.35 | $0.10 | −$0.17 | $0.19 | $0.20 | $1.13 | $0.06 | −$0.91 |
| Diluted shares | 0.01B | 0.02B | 0.02B | 0.03B | 0.05B | 0.06B | 0.07B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | −$2.2M | $12.6M | $24.8M | $36.4M | $34.5M | $69.0M | $76.5M | $68.4M | $70.0M | $73.6M |
| Depreciation and amortization | $2.3M | $7.9M | $13.6M | $19.1M | $26.7M | $33.8M | $40.0M | $41.3M | $40.4M | $44.0M |
| Stock-based compensation | $1.7M | $1.8M | $2.7M | $3.3M | $5.3M | $5.8M | $4.7M | $4.2M | $5.1M | $4.5M |
| Acquisitions | — | — | $0.0M | $0.0M | $5.1M | $0.0M | $0.0M | — | — | — |
| Share buybacks | — | — | — | — | — | — | — | — | — | $6.0M |
| Dividends paid | $0.0M | $0.7M | $5.8M | $5.8M | $5.8M | $5.8M | $5.8M | $5.8M | $5.8M | $5.8M |
| Dividends and buybacks | $0.0M | $0.7M | $5.8M | $5.8M | $5.8M | $5.8M | $5.8M | $5.8M | $5.8M | $11.8M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $19.7M | $5.1M | $3.6M | $2.8M | $5.5M | $7.2M | $4.0M | $1.3M | $6.8M | $9.1M |
| Total debt | — | — | — | — | — | — | — | — | $14.4M | $1.2M |
| Goodwill | — | — | — | $0.0M | $5.9M | $5.9M | $5.9M | $5.9M | $5.9M | $5.9M |
| Intangible assets | $7.1M | $29.3M | $59.1M | $59.1M | $73.3M | $87.7M | $91.2M | $65.5M | $53.7M | $46.0M |
| Total assets | $227M | $472M | $636M | $885M | $1.1B | $1.3B | $1.4B | $1.3B | $1.3B | $1.2B |
| Total liabilities | $72.3M | $213M | $336M | $425M | $643M | $626M | $744M | $662M | $701M | $712M |
| Preferred stock | $0.0M | $75.0M | $75.0M | $75.0M | $75.0M | $75.0M | $75.0M | $75.0M | $75.0M | $124M |
| Shareholders' equity | $155M | $246M | $269M | $430M | $445M | $623M | $633M | $584M | $534M | $510M |
| Margins | ||||||||||
| Net margin | −77.4% | −0.3% | 27.4% | 13.6% | −2.7% | 15.8% | 14.6% | 15.4% | 4.8% | −4.6% |
| Returns | ||||||||||
| Return on equity | −4.1% | −0.0% | 5.6% | 2.7% | −0.6% | 3.4% | 3.2% | 3.6% | 1.2% | −1.3% |
| Return on assets | −2.8% | −0.0% | 2.6% | 1.3% | −0.3% | 1.6% | 1.5% | 1.6% | 0.5% | −0.6% |
| Return on tangible equity | −4.3% | −0.8% | 3.6% | 0.9% | −2.1% | 2.2% | 2.5% | 2.9% | 0.2% | −2.6% |
| Growth | ||||||||||
| Revenue growth | — | 269.6% | 75.3% | 33.0% | 32.5% | 23.7% | 18.4% | 2.7% | −1.6% | 6.8% |
| Net income growth | — | — | — | −34.2% | −126.1% | — | 9.0% | 8.7% | −69.2% | −202.9% |
| EPS growth | — | — | — | −71.4% | −270.0% | — | 5.3% | 465.0% | −94.7% | −1,616.7% |
| Share count change | — | 110.9% | 12.0% | 54.1% | 36.6% | 31.1% | 8.0% | −80.0% | 0.6% | 1.5% |
| Financial health | ||||||||||
| Debt / equity | — | — | — | — | — | — | — | — | 0.0x | 0.0x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 20.5% | 5.9% | 5.0% | 4.7% | 5.7% | 5.0% | 3.4% | 3.0% | 3.7% | 3.0% |
| Quality scores | ||||||||||
| Piotroski F-score | — | — | — | — | — | — | — | — | — | 4.0 |
| Accruals ratio | −1.8% | −3.6% | −1.9% | −3.5% | −3.7% | −4.3% | −4.3% | −3.5% | −5.0% | −6.4% |
Source: SEC EDGAR XBRL filings (CIK 0001533615). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
